Global Single Use Consumables Market Size, Trend & Opportunity Analysis Report, by Product (Tubing, Connectors, Disconnectors, Adapters, Valves, Capsule Filter, Sensors), Application (Filtration, Storage, Cell Culture, Sampling), End User (Biotech, Pharma, CROs & CMOs, OEMs), and Forecast, 2025-2035
Global Single Use Consumables Market Size, Opportunity Analysis and Forecast, 2025-2035
Market Definition and Introduction
The Global Single-Use Consumables Market, valued at USD 2.99 billion in 2024, is slated to increase exponentially to USD 16.82 billion by 2035, with a remarkable CAGR of 17.00% projected during the forecast period 2025-2035. Single-use consumables began to play the role of major enablers in both upstream and downstream processes as the biomanufacturing sector started looking for greater operational agility and cost-effectiveness. These disposable items, which may include anything from tubing and connectors to filters and sensors, are changing sterile work processes with the reduced need for cleaning validation, decreased contamination risks, and increased throughput. The requirement for new paradigms in consumables is being fuelled by the need for fast scale-up of vaccine and therapeutic production, along
with a preference for compact and modular bioproduction setups.
Transition towards the advanced single-use technologies is also enabled by the global boom in the manufacturing of biologics and personalised medicine. As biopharmaceutical developers look for flexible and closed-loop systems that will accommodate varying batch sizes, the change from conventional stainless-steel equipment to disposable technologies is becoming both strategic and inevitable. These consumables not only facilitate the smooth running of production processes but also help maintain GMP compliance as standardised and pre-validated components are seamlessly integrated in hybrid manufacturing systems. This trend is also accelerated by the emergence of CDMOs and CROs with multi-product facilities that necessitate the use of plug-and-play consumables with rapid changeover capabilities to minimise downtime.
Concerning regulatory authorities, global health agencies are beginning to endorse the efficacy and reliability of single-use systems as they pertain to aseptic processing and advanced therapy production. Against this backdrop, OEMs and pharmaceutical organisations have been investing aggressively in the next generation of consumables that lend themselves either fully or partially to automation, digital process monitoring, and high-throughput environments. With sustainability gaining its due consideration, disposable systems are increasingly expected to accommodate biodegradable or recyclable options that present a more favourable environmental path forward.
Recent Developments in the Industry
- In February 2024, Thermo Fisher Scientific launched its new range of high-integrity gamma-irradiated capsule filters designed for single-use bioprocessing, catering specifically to large-scale mRNA and recombinant protein production.
- In November 2023, Sartorius AG announced the expansion of its production facility in Tunisia to manufacture advanced single-use sensors and connectors, aimed at addressing supply chain challenges in bioprocess consumables.
- In July 2023, Merck KGaA introduced its smart single-use sampling system equipped with real-time analytics capabilities, offering biomanufacturers greater control over critical process parameters.
- In April 2023, Avantor Inc. completed its acquisition of Masterflex Bioprocessing Tubing from Antylia Scientific, a move intended to expand its portfolio of precision fluid handling solutions for disposable systems.
Market Dynamics
Construction of an Accelerated Biologics Production Facility That Will Further Intensify Demand for Modular Technologies with Sterile and
Disposable Capabilities.
An increasing number of highly complex biologic therapies, including mAbs, recombinant proteins, and cell and gene therapies, have been forcing manufacturers to go for disposable process solutions that guarantee sterility assurance and fast turnaround capacity. One-time use consumables allow organisations to limit cleaning cycles for equipment, reduce possible cross-contamination risks, and streamline the state processes. This is particularly critical in multi-product facilities or for clinical trials.
Outsourcing Trends to Increase Demand for Flexible Pre-Sterilised Consumables
The growing dependency of pharmaceutical and biotech companies on outsourcing their manufacturing to CDMO and CRO drives an increasing demand for standard validated consumables to ensure process integrity in all manufacturing sites. These outsourcing partners run on compressed timelines, as it is, disposing of consumables for works such as connectors, filters, and flow paths, which need only minimal pipeline placement to be ready for use.
Automated and Digital Integration Propelled the Need for Sensor-Embedded Single-Use Components
New Industry trends regarding 4.0 in biomanufacturing create a huge demand for single-use sensors, which provide real-time monitoring of highly critical process parameters, i.e., pH, pressure, and dissolved oxygen. These intelligent consumables play an important role in the formation of closed-loop control systems and automated bioproduction workflows for continuous manufacturing and perfusion-based cultures.
Sustainability Pressures Spark New Innovations in Eco-Friendly, Recyclable Single-Use Systems
Concerns regarding environmental impact from plastic waste are prompting manufacturers to invest in recyclable and biodegradable single-use alternatives. Green materials have not yet become mainstream, but innovations in polymer sciences are beginning to provide options available for sustainability-conscious organisations that challenge developing the balance between creating sterility and ecological responsibility.
Regulatory Support for Adoption of Single-Use Technology Increases Its Global Deployment Potential
Regulatory agencies such as the U.S. FDA and EMA are now issuing guidance regarding validation and qualification of single-use systems, referring especially to sterile fill-finish and advanced therapy production lines. Alignment of such regulations should lower the barrier to entry for adopting standardised consumable products and improve their marketability across borders.
Attractive Opportunities in the Market
- Widespread Biomanufacturing Adoption - Bioprocess facilities rapidly shift from stainless steel to single-use systems.
- Advanced Therapy Manufacturing - Cell, gene, and viral vector therapies mandate high-integrity, sterile consumables.
- Outsourced Production Uptick - CDMOs & CROs rely on modular, disposable components for faster changeovers.
- Smart Sensor Integration - Demand grows for data-driven consumables with real-time analytics capabilities.
- Filtration Innovation - Advanced capsule filters optimise downstream purification workflows.
- Supply Chain Decentralisation - Regional hubs require flexible, portable bioproduction kits.
- Automation-Compatible Designs - Plug-and-play disposables support AI-enabled, closed-loop bioprocessing.
- Eco-Conscious Materials - Recyclable and biodegradable alternatives begin disrupting traditional consumables.
Report Segmentation
By Product: Tubing, Connectors, Disconnectors, Adapters, Valves, Capsule Filter, Sensors
By Application: Filtration, Storage, Cell Culture, Sampling
By End User: Biotech, Pharma, CROs & CMOs, OEMs
By Region: North America (U.S., Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, Spain, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, Rest of Asia-Pacific), LAMEA (Brazil, Argentina, UAE, Saudi Arabia (KSA), Africa, Rest of Latin America)
Key players: Charles River Laboratories, SGS SA, Eurofins Scientific, Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group, Sartorius AG, WuXi AppTec, BioOutsource Ltd (a Sartorius company), and Toxikon Corporation.
Report Aspects
Base Year: 2024
Historic Years: 2022, 2023, 2024
Forecast Period: 2025-2035
Report Pages: 293
Dominating Segments
Tubing Section Leads in the Single-Use Consumables Market, Which Is Also Supplemented by Broader Bioprocess Applicability and Scalability
An array of tubing systems forms the operational basis for single-use bioprocessing, linking fluid transfer systems between unit operations while maintaining processes in sterile integrity. Widespread application of tubing systems in filtration, cell culture, and sampling has made them the neediest part of the market. However, the use of advanced thermoplastic elastomers and fluoropolymer materials has enhanced resistance to pressure, temperature, and chemical stress. Manufacturers have started producing gamma-stable versions of these tubes to adapt them to sterilisation methods. With biopharmaceutical facilities desirous of modularity and reduced validation cycles, there is a fast set-up to standardise processes using pre-assembled tubing sets.
Filtration Applications as Core Functional Pillars in Disposable Biomanufacturing Systems
These consumables, from depth filters to capsule filters, deliver contamination-free processing of high-value therapeutics. Filtration, as the nucleus of single-use technology, will facilitate the purification, sterilisation, and separation of biomolecules under sterile conditions. The growing incidence of biologics, the introduction of vaccine candidates, and the manufacture of products derived from plasma all favour the manufacturing industry. Pre-validated disposable filtration systems have surged onto the horizon. Manufacturers keep on innovating to enhance filter capacity, hold-up volumes, and integrate inline sensors for pressure monitoring. Disposal filtration configurations are, more than any other, setting fresh standards as continuous production takes root, with boosting process efficiency and containment of costs in mind.
Biotech End Users Driving Growth in the Market through Demand for Agile Manufacturing and Customised Changes
Biotechnology has been at the forefront of single-use consumables, with fast development in cell and gene therapy. This high-value, low-batch production, typical of biotechnology firms, sits very well with the flexibility and scalability that single-use systems have to offer. With precision therapeutics defining the ground on which success, after significant investments, can be made, biotech is now investing in custom single-use assemblies for its upstream and downstream processing. The increasing reliance on contract research and manufacturing partnerships is, however, broadening the adoption landscape, consequently making single-use technologies the default infrastructure across biologics production pipelines.
Key Takeaways
- Sterility First - Single-use systems drive contamination control and process consistency.
- Smart Bioprocessing - Embedded sensors accelerate shift toward digitally-enabled manufacturing.
- Modular Design Adoption - Rapid assembly and integration redefine flexible bioproduction workflows.
- CRO and CDMO Expansion - Outsourcing fuels demand for pre-validated, disposable components.
- Future-Ready Consumables - Biologic, cell, and gene therapy pipelines spark innovative use cases.
- Eco Trends Emerging - Shift toward recyclable and sustainable single-use solutions gaining momentum.
- Automation Drives Change - Seamless integration with robotic and continuous manufacturing processes.
- Regional Hubs Rise - APAC and LATAM investments create new demand centres for consumables.
- Regulatory Embrace - Global harmonisation paves the way for broader adoption.
- Material Science Innovation - High-performance polymers improve reliability and fluid compatibility.
Regional Insights
North America is holding a relentless lead regarding the consumables market on account of a good number of biopharma manufacturers.
North America is holding a relentless lead regarding the consumables market on account of a good number of biopharma manufacturers, high spending CDMOs, and a rapidly growing biologics pipeline. Consumption is most notably seen in the United States due to the momentum driven by monoclonal antibody production, wide clinical trials, and the very early adoption of digital biomanufacturing. Agencies like the FDA are promoting regulations in favour of the standardised validation of single-use components and are encouraging their wider
use.
Europe's Biomanufacturing Infrastructure Leads to the Constant Innovation of Disposable Systems
Europe ranks as the second major commonality around the world, with countries like Germany, Switzerland, and the UK investing in sophisticated bioproduction facilities that strive for cleanroom efficiency and the banishment of contamination. This focus, followed by GMP procedures and other environmental values, has disciplined the research into green component business development and disposable systems. Collaborations involving OEMs, universities, and government bodies are highly appreciated to foster the creation of a more developed disposable system and its market linkage.
Asia-Pacific Region is the Fast-Emerging Market for Single-Use Consumables
Being directed towards the sudden crescendo in demand, the Asia-Pacific region holds a very high chance of consuming single-use consumables. Yet, a considerable investment in the biologics landscape, with the presence of highly skilled professionals and government-sanctioned biotech innovation hubs, underpins the foundation for this growth. China, India, South Korea, and Singapore have been acknowledged for bulking up their local manufacturing capacities while sharing support with global biologic supply chains. In APAC, the CROs and CMOs have an interest in the usage of disposable instruments for maintaining the system portability, scalability, and regulatory harmony.
LAMEA Region Sees the Adoption of Technology Gradually Pushed by Healthcare Modernisation
Single-use technologies are being continually integrated in the pharmaceutical and biotechnological workflows in the regions of Latin America and the Middle East & and Africa. Strategic partnership investments are being made by ways of countries like Brazil and Saudi Arabia into building local manufacturing. OEMs are motivated to act as partners for their regional counterparts in introducing modular consumable kits suitable for various climatic and infrastructural needs.
Key Benefits for Stakeholders
- The report offers a quantitative assessment of market segments, emerging trends, projections, and market dynamics for the period 2024 to 2035.
- The report presents comprehensive market research, including insights into key growth drivers, challenges, and potential opportunities.
- Porter's Five Forces analysis evaluates the influence of buyers and suppliers, helping stakeholders make strategic, profit-driven decisions and strengthen their supplier-buyer relationships.
- A detailed examination of market segmentation helps identify existing and emerging opportunities.
- Key countries within each region are analysed based on their revenue contributions to the overall market.
- The positioning of market players enables effective benchmarking and provides clarity on their current standing within the industry.
- The report covers regional and global market trends, major players, key segments, application areas, and strategies for market expansion.
Frequently Asked Question(FAQ) :
The transition is driven by the need for greater operational agility and cost-effectiveness. Single-use technologies reduce the need for complex cleaning validation, decrease cross-contamination risks, increase throughput, and allow for faster scale-up of vaccine and therapeutic production.
Tubing and filtration systems are the leading segments. Tubing serves as the operational basis for fluid transfer between unit operations, while filtration consumables (such as capsule filters) are critical for the purification and sterilization of high-value biomolecules.
There is a growing demand for "smart" consumables embedded with sensors. These components allow for real-time digital monitoring of critical process parameters such as pH, pressure, and dissolved oxygen, facilitating automated bioproduction and closed-loop control systems.
Contract Development and Manufacturing Organizations (CDMOs) and Clinical Research Organizations (CROs) are major drivers of demand. Because they operate multi-product facilities with compressed timelines, they rely on pre-validated, "plug-and-play" disposable consumables to achieve rapid changeover and minimize downtime.
Sustainability is becoming a strategic priority. Manufacturers are increasingly investing in the development of eco-friendly, biodegradable, or recyclable single-use alternatives through innovations in polymer science to balance sterility requirements with ecological responsibility.
North America currently holds the lead due to its extensive biopharma manufacturing base and early adoption of digital biomanufacturing. However, the Asia-Pacific region is the fastest-emerging market, fueled by significant investments in biologics and biotech innovation hubs in China, India, and South Korea.
Global health agencies like the U.S. FDA and EMA are increasingly endorsing single-use systems. They are providing specific guidance on the validation and qualification of these systems for aseptic processing, which helps standardize components and lowers the barrier to entry for manufacturers.
Advanced therapies often involve high-value, low-batch production that requires extreme sterility assurance. Single-use assemblies provide the necessary flexibility and scalability, making them the default infrastructure for the complex manufacturing requirements of cell and gene therapy pipelines.
Recent developments include Thermo Fisher Scientific’s launch of gamma-irradiated capsule filters for mRNA production, Sartorius AG’s facility expansion in Tunisia for sensors and connectors, Merck KGaA’s introduction of smart sampling systems, and Avantor’s acquisition of Masterflex to expand its precision fluid handling portfolio.
